Rendering
| Component: (Network and Table) |
|---|
| Network | 31103 - Disclosure - Income Taxes (Tables) (http://www.agiletherapeutics.com/role/DisclosureIncomeTaxesTables) |
| Table | (Implied) |
Slicers (applies to each fact value in each table cell)
| Reporting Entity [Axis] | 0001261249 (http://www.sec.gov/CIK) |
| Income Taxes | Period [Axis] |
|---|
2016-01-01 - 2016-12-31 |
|---|
Income Taxes | |
Schedule of tax effects of temporary differences that give rise to significant portions of deferred tax assets |
|
|
|
December 31
|
|
|
|
|
2016
|
|
2015
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
63,068
|
|
$
|
54,197
|
|
|
Research credit carryforward
|
|
|
5,284
|
|
|
4,527
|
|
|
Stock options and other
|
|
|
2,250
|
|
|
1,474
|
|
|
|
|
|
|
|
|
|
|
|
Total gross deferred tax assets
|
|
|
70,602
|
|
|
60,198
|
|
|
Valuation allowance for deferred tax assets
|
|
|
(70,602
|
)
|
|
(60,198
|
)
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax assets
|
|
$
|
—
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of reconciliation of U.S. statutory income tax rate to effective tax rate |
|
|
|
December 31,
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
|
|
Federal income tax at statutory rate
|
|
|
34.0
|
%
|
|
34.0
|
%
|
|
34.0
|
%
|
|
State income tax benefit, net of federal benefit
|
|
|
6.0
|
%
|
|
6.0
|
%
|
|
6.0
|
%
|
|
Research and development tax credits
|
|
|
2.0
|
%
|
|
2.0
|
%
|
|
3.0
|
%
|
|
Other
|
|
|
1.0
|
%
|
|
(2.0
|
)%
|
|
—
|
%
|
|
Increase to valuation allowance
|
|
|
(33.0
|
)%
|
|
(24.0
|
)%
|
|
(24.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
10.0
|
%
|
|
16.0
|
%
|
|
19.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|